231 related articles for article (PubMed ID: 16579994)
1. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
Singhal SS; Wickramarachchi D; Singhal J; Yadav S; Awasthi YC; Awasthi S
FEBS Lett; 2006 Apr; 580(9):2258-64. PubMed ID: 16579994
[TBL] [Abstract][Full Text] [Related]
2. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76.
Awasthi S; Singhal SS; Singhal J; Cheng J; Zimniak P; Awasthi YC
Int J Oncol; 2003 Apr; 22(4):713-20. PubMed ID: 12632060
[TBL] [Abstract][Full Text] [Related]
3. Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.
Singhal SS; Yadav S; Singhal J; Awasthi YC; Awasthi S
Biochem Biophys Res Commun; 2006 Sep; 348(2):722-7. PubMed ID: 16890208
[TBL] [Abstract][Full Text] [Related]
4. The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.
Singhal SS; Yadav S; Singhal J; Drake K; Awasthi YC; Awasthi S
FEBS Lett; 2005 Aug; 579(21):4635-41. PubMed ID: 16087181
[TBL] [Abstract][Full Text] [Related]
5. Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells.
Singhal SS; Singhal J; Sharma R; Singh SV; Zimniak P; Awasthi YC; Awasthi S
Int J Oncol; 2003 Feb; 22(2):365-75. PubMed ID: 12527936
[TBL] [Abstract][Full Text] [Related]
6. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity.
Awasthi S; Singhal SS; Singhal J; Yang Y; Zimniak P; Awasthi YC
Int J Oncol; 2003 Apr; 22(4):721-32. PubMed ID: 12632061
[TBL] [Abstract][Full Text] [Related]
7. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
Singhal SS; Yadav S; Singhal J; Zajac E; Awasthi YC; Awasthi S
Biochem Pharmacol; 2005 Aug; 70(3):481-8. PubMed ID: 15950949
[TBL] [Abstract][Full Text] [Related]
8. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.
Sharma R; Singhal SS; Wickramarachchi D; Awasthi YC; Awasthi S
Int J Cancer; 2004 Dec; 112(6):934-42. PubMed ID: 15386349
[TBL] [Abstract][Full Text] [Related]
9. RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
Stuckler D; Singhal J; Singhal SS; Yadav S; Awasthi YC; Awasthi S
Cancer Res; 2005 Feb; 65(3):991-8. PubMed ID: 15705900
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer.
Singhal SS; Singhal J; Nair MP; Lacko AG; Awasthi YC; Awasthi S
Int J Oncol; 2007 Mar; 30(3):717-25. PubMed ID: 17273774
[TBL] [Abstract][Full Text] [Related]
11. Role of RLIP76 in doxorubicin resistance in lung cancer.
Vatsyayan R; Chaudhary P; Lelsani PC; Singhal P; Awasthi YC; Awasthi S; Singhal SS
Int J Oncol; 2009 Jun; 34(6):1505-11. PubMed ID: 19424567
[TBL] [Abstract][Full Text] [Related]
12. [Role and clinical significance of RLIP76 in regulation of multi-drug resistance of small cell lung cancer].
Haixia P; Yifeng B; Honglin H
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):266-71. PubMed ID: 26462890
[TBL] [Abstract][Full Text] [Related]
13. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
Singhal SS; Sehrawat A; Sahu M; Singhal P; Vatsyayan R; Rao Lelsani PC; Yadav S; Awasthi S
Int J Cancer; 2010 Mar; 126(6):1327-38. PubMed ID: 19626587
[TBL] [Abstract][Full Text] [Related]
14. RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin.
Mi J; Zhang X; Rabbani ZN; Liu Y; Reddy SK; Su Z; Salahuddin FK; Viles K; Giangrande PH; Dewhirst MW; Sullenger BA; Kontos CD; Clary BM
Mol Ther; 2008 Jan; 16(1):66-73. PubMed ID: 17912235
[TBL] [Abstract][Full Text] [Related]
15. Targeting p53-null neuroblastomas through RLIP76.
Singhal J; Yadav S; Nagaprashantha LD; Vatsyayan R; Singhal SS; Awasthi S
Cancer Prev Res (Phila); 2011 Jun; 4(6):879-89. PubMed ID: 21411502
[TBL] [Abstract][Full Text] [Related]
16. POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis.
Yadav S; Zajac E; Singhal SS; Singhal J; Drake K; Awasthi YC; Awasthi S
Biochem Biophys Res Commun; 2005 Mar; 328(4):1003-9. PubMed ID: 15707977
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
[TBL] [Abstract][Full Text] [Related]
18. Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.
Singhal SS; Yadav S; Singhal J; Sahu M; Sehrawat A; Awasthi S
FEBS Lett; 2008 Oct; 582(23-24):3408-14. PubMed ID: 18789326
[TBL] [Abstract][Full Text] [Related]
19. Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences.
Awasthi S; Cheng JZ; Singhal SS; Pandya U; Sharma R; Singh SV; Zimniak P; Awasthi YC
Biochemistry; 2001 Apr; 40(13):4159-68. PubMed ID: 11300797
[TBL] [Abstract][Full Text] [Related]
20. Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1.
Cao Z; Liang N; Yang H; Li S
Cell Prolif; 2017 Oct; 50(5):. PubMed ID: 28762597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
